Windlas Biotech Ltd - 543329 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to the Regulation 24A of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are forwarding herewith the Annual Secretarial Compliance Report for the financial year 2022-23. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Q4 FY23 Earnings Conference Call Transcript. Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018
Pursuant to the provisions of Regulation 21 read with Regulation 11 of the Buy-back Regulations, the Company has completed the extinguishment of 68,603 (Sixty Eight Thousand Six Hundred and Three) equity shares bought back under the Buy-back during the period from April 26, 2023 till May 02, 2023. In connection with the same, we are submitting herewith details of extinguishment along with the debit confirmation letter received from the Central Depository Services Limited and Certificate of Extinguishment for your records. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 2018 Windlas Biotech Ltd - 543329 - Recording Of Conferencing Call
Recording of Conferencing call Windlas Biotech Ltd - 543329 - Updates on Buyback Offer
Corporate Professionals Capital Pvt Ltd ("Manager to the Buyback") has informed BSE about "Update on Buyback amount". Windlas Biotech Ltd - 543329 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Related Party Transactions on a consolidated basis, in the format specified in the relevant accounting standards for the half year period from October 01, 2022 to March 31, 2023 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report dated April 29, 2023, in respect of utilization of proceeds of IPO for the quarter ended March 31, 2023 issued by M/s. HDFC Bank Limited Windlas Biotech Ltd - 543329 - Statement Of Deviation For The Quarter Ended March 31, 2023
Statement of Deviation for the quarter ended March 31, 2023 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith the Results Presentation for the Quarter and Financial Year ended March 31, 2023 for your records.